Changing patterns in the incidence of esophageal and gastric carcinoma in the United States - PubMed (original) (raw)
. 1998 Nov 15;83(10):2049-53.
Affiliations
- PMID: 9827707
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
S S Devesa et al. Cancer. 1998.
Abstract
Background: Incidence rates for esophageal adenocarcinoma previously were reported to be increasing rapidly, especially among white males. Rates for gastric cardia adenocarcinoma also were observed to be rising, although less rapidly. In this article, the authors update the incidence trends through 1994 and further consider the trends by age group.
Methods: Surveillance, Epidemiology, and End Results (SEER) program data were used to calculate age-adjusted incidence rates for esophageal carcinoma by histologic type and gastric adenocarcinoma by anatomic subsite.
Results: Among white males, the incidence of adenocarcinoma of the esophagus rose > 350% since the mid-1970s, surpassing squamous cell carcinoma around 1990. Rates also rose among black males, but remained at much lower levels. To a lesser extent, there were continuing increases in gastric cardia adenocarcinoma among white and black males, which nearly equaled the rates for noncardia tumors of the stomach in white men. The upward trend for both tumors was much greater among older than younger men. Although the incidence also rose among females, rates remained much lower than among males.
Conclusions: Previously reported increases of esophageal adenocarcinoma are continuing, most notably among white males. Cigarette smoking may contribute to the trend through an early stage carcinogenic effect, along with obesity, which may increase intraabdominal pressure and predispose to gastroesophageal reflux disease. Further research into esophageal and gastric cardia adenocarcinoma is needed to clarify the risk factors and mechanisms responsible for the upward trends as well as the racial and gender disparities in incidence.
Similar articles
- Incidence of esophageal and gastric carcinomas among American Asians/Pacific Islanders, whites, and blacks: subsite and histology differences.
Wu X, Chen VW, Ruiz B, Andrews P, Su LJ, Correa P. Wu X, et al. Cancer. 2006 Feb 1;106(3):683-92. doi: 10.1002/cncr.21542. Cancer. 2006. PMID: 16388522 - Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences.
Wu X, Chen VW, Andrews PA, Ruiz B, Correa P. Wu X, et al. Cancer Causes Control. 2007 Aug;18(6):585-93. doi: 10.1007/s10552-007-9000-1. Epub 2007 Apr 4. Cancer Causes Control. 2007. PMID: 17406989 - Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States.
Kubo A, Corley DA. Kubo A, et al. Cancer. 2002 Nov 15;95(10):2096-102. doi: 10.1002/cncr.10940. Cancer. 2002. PMID: 12412162 - Epidemiology of upper gastrointestinal malignancies.
Crew KD, Neugut AI. Crew KD, et al. Semin Oncol. 2004 Aug;31(4):450-64. doi: 10.1053/j.seminoncol.2004.04.021. Semin Oncol. 2004. PMID: 15297938 Review. - Epidemiologic trends in esophageal and gastric cancer in the United States.
Brown LM, Devesa SS. Brown LM, et al. Surg Oncol Clin N Am. 2002 Apr;11(2):235-56. doi: 10.1016/s1055-3207(02)00002-9. Surg Oncol Clin N Am. 2002. PMID: 12424848 Review.
Cited by
- Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.
Ghaus S, Neumann H, Muhammad H, Tontini GE, Ishaq S. Ghaus S, et al. Dig Dis Sci. 2016 Aug;61(8):2185-2193. doi: 10.1007/s10620-016-4138-x. Epub 2016 Apr 1. Dig Dis Sci. 2016. PMID: 27038446 Review. - Comparison of advanced adenocarcinomas of esophagogastric junction and distal stomach in Japanese patients.
Kawano A, Nakajima TE, Oda I, Hokamura N, Iwasa S, Kato K, Hamaguchi T, Yamada Y, Fujii H, Shimada Y. Kawano A, et al. Gastric Cancer. 2014 Jan;17(1):54-60. doi: 10.1007/s10120-013-0238-x. Epub 2013 Feb 24. Gastric Cancer. 2014. PMID: 23435842 Clinical Trial. - Tumors of the gastroesophageal junction have intermediate prognosis compared to tumors of the esophagus and stomach, but share the same clinical determinants.
Gobbi PG, Bergonzi M, Pozzoli D, Villano L, Vanoli A, Corbella F, Dionigi P, Corazza GR. Gobbi PG, et al. Oncol Lett. 2011 May;2(3):503-507. doi: 10.3892/ol.2011.278. Epub 2011 Mar 21. Oncol Lett. 2011. PMID: 22866111 Free PMC article. - Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS, Lapin B, Wang C, Goldstein JL, Linn JG, Denham W, Haggerty SP, Talamonti MS, Howington JA, Carbray J, Ujiki MB. Brown CS, et al. Surg Endosc. 2015 Dec;29(12):3528-34. doi: 10.1007/s00464-015-4103-3. Epub 2015 Feb 13. Surg Endosc. 2015. PMID: 25676204 - Urease inhibitory activities of β-boswellic acid derivatives.
Golbabaei S, Bazl R, Golestanian S, Nabati F, Omrany ZB, Yousefi B, Hajiaghaee R, Rezazadeh S, Amanlou M. Golbabaei S, et al. Daru. 2013 Jan 2;21(1):2. doi: 10.1186/2008-2231-21-2. Daru. 2013. PMID: 23351363 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical